Benitec Biopharma (BNTC) Non Operating Income (2019 - 2025)
Benitec Biopharma (BNTC) reported Non Operating Income of $1.5 million for Q4 2025, up 22.91% on a YoY basis from $1.3 million in Q4 2024, and up 83.77% sequentially from $838000.0 in Q3 2025.
Benitec Biopharma (BNTC) Non Operating Income (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Non Operating Income data on file, last reported at $1.5 million in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income rose 22.91% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $4.2 million (up 42.84% YoY), and the FY2025 full-year result was $3.8 million, up 325.66% from the prior year.
- Non Operating Income improved to $1.5 million in Q4 2025, from $838000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.5 million in Q4 2025 to a low of -$329000.0 in Q2 2022.
- A 5-year average of $347850.0 and a median of $130500.0 in 2021 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income plunged 1388.89% in 2021 and jumped 20950.0% in 2025, its largest moves.
- Tracing BNTC's Non Operating Income over 5 years: stood at $14000.0 in 2021, then jumped by 1321.43% to $199000.0 in 2022, then plunged by 35.18% to $129000.0 in 2023, then soared by 871.32% to $1.3 million in 2024, then climbed by 22.91% to $1.5 million in 2025.
- Business Quant data shows BNTC's Non Operating Income at $1.5 million in Q4 2025, $838000.0 in Q3 2025, and $1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Benitec Biopharma | 46.45 Mn | 46.45 Mn | - | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 838,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 732,000.00 |
| Jun 30, 2024 | 993,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Sep 30, 2023 | -80,000.00 |
| Jun 30, 2023 | -111,000.00 |
| Mar 31, 2023 | -56,000.00 |
| Dec 31, 2022 | 199,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | -329,000.00 |
| Mar 31, 2022 | 185,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | -223,000.00 |
| Jun 30, 2021 | 132,000.00 |
| Mar 31, 2021 | -116,000.00 |